JP2009526084A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009526084A5 JP2009526084A5 JP2008554516A JP2008554516A JP2009526084A5 JP 2009526084 A5 JP2009526084 A5 JP 2009526084A5 JP 2008554516 A JP2008554516 A JP 2008554516A JP 2008554516 A JP2008554516 A JP 2008554516A JP 2009526084 A5 JP2009526084 A5 JP 2009526084A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- pharmaceutical composition
- composition according
- inflammatory
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77217706P | 2006-02-10 | 2006-02-10 | |
| US78107806P | 2006-03-10 | 2006-03-10 | |
| PCT/US2007/061909 WO2008039553A1 (en) | 2006-02-10 | 2007-02-09 | Soluble il-17rcx4 and methods of using in inflammation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009526084A JP2009526084A (ja) | 2009-07-16 |
| JP2009526084A5 true JP2009526084A5 (enExample) | 2010-03-18 |
Family
ID=38895865
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008554516A Pending JP2009526084A (ja) | 2006-02-10 | 2007-02-09 | 可溶性ＩＬ−１７ＲＣｘ４および炎症における使用法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7622116B2 (enExample) |
| EP (1) | EP1987058B1 (enExample) |
| JP (1) | JP2009526084A (enExample) |
| AT (1) | ATE467640T1 (enExample) |
| AU (1) | AU2007300393B2 (enExample) |
| CA (1) | CA2638819A1 (enExample) |
| DE (1) | DE602007006429D1 (enExample) |
| ES (1) | ES2347840T3 (enExample) |
| IL (1) | IL192950A0 (enExample) |
| WO (1) | WO2008039553A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0511952A (pt) * | 2004-06-10 | 2008-01-29 | Zymogenetics Inc | receptor solúvel isolado, anticorpo ou fragmento de anticorpo, e, métodos de reduzir inflamação induzida por il-17a ou induzida por il-17f, de tratar um mamìfero afetado com uma doença inflamatória, e uma condição patológica em um indivìduo associada com atividade de zcytor14 |
| JP2010522564A (ja) | 2007-03-26 | 2010-07-08 | ザイモジェネティクス， インコーポレイテッド | 可溶性ｉｌ−１７ｒａ／ｒｃ融合タンパク質および関連する方法 |
| JP5237366B2 (ja) * | 2007-06-20 | 2013-07-17 | メルク・シャープ・アンド・ドーム・コーポレーション | 炎症性関節疾患に対する抗ｉｌ−１７ａ治療のための関節破壊のバイオマーカー |
| GB2464183A (en) * | 2008-09-19 | 2010-04-14 | Singulex Inc | Sandwich assay |
| US9238878B2 (en) | 2009-02-17 | 2016-01-19 | Redwood Bioscience, Inc. | Aldehyde-tagged protein-based drug carriers and methods of use |
| TW201613969A (en) * | 2009-03-05 | 2016-04-16 | Abbvie Inc | IL-17 binding proteins |
| AU2010259022B2 (en) | 2009-06-08 | 2016-05-12 | Singulex, Inc. | Highly sensitive biomarker panels |
| JP2011032170A (ja) * | 2009-07-29 | 2011-02-17 | Morinaga Milk Ind Co Ltd | ヒト細胞ｉｌ−１７産生抑制剤 |
| JPWO2011096438A1 (ja) * | 2010-02-03 | 2013-06-10 | 国立大学法人 東京大学 | 腸疾患の治療方法及び治療用医薬組成物 |
| US20110301053A1 (en) | 2010-05-06 | 2011-12-08 | Singulex, Inc. | Methods for Diagnosing, Staging, Predicting Risk for Developing and Identifying Treatment Responders for Rheumatoid Arthritis |
| RU2535033C2 (ru) * | 2010-08-06 | 2014-12-10 | Олег Ильич Эпштейн | Лекарственное средство и способ профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида |
| JP6162606B2 (ja) | 2011-01-14 | 2017-07-12 | レッドウッド バイオサイエンス， インコーポレイテッド | アルデヒド−タグ付き免疫グロブリンポリペプチド及びその使用方法 |
| WO2013116682A1 (en) | 2012-02-02 | 2013-08-08 | Ensemble Therapeutics Corporation | Macrocyclic compounds for modulating il-17 |
| MY207225A (en) | 2015-10-27 | 2025-02-06 | UCB Biopharma SRL | Methods of treatment using anti-il-17a/f antibodies |
| CN109071634A (zh) | 2016-04-26 | 2018-12-21 | R.P.谢勒技术有限责任公司 | 抗体偶联物及其制备和使用方法 |
| WO2020147829A1 (zh) * | 2019-01-17 | 2020-07-23 | 北京百奥赛图基因生物技术有限公司 | 人源化转基因动物 |
| CN114599665A (zh) | 2019-08-16 | 2022-06-07 | 应用分子转运公司 | 组合物、制剂及白细胞介素产生和纯化 |
| CN112250764B (zh) * | 2020-10-22 | 2022-07-29 | 深圳市康瑞克生物科技有限责任公司 | 一种抗白细胞介素17a的单克隆抗体、其编码基因及应用 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5684032A (en) | 1994-12-13 | 1997-11-04 | Smithkline Beecham Corporation | Compounds |
| MX9707021A (es) | 1995-03-23 | 1997-11-29 | Immunex Corp | Receptor de il-7. |
| US5945511A (en) | 1997-02-20 | 1999-08-31 | Zymogenetics, Inc. | Class II cytokine receptor |
| US6579520B2 (en) | 1998-05-15 | 2003-06-17 | Genentech, Inc. | IL-17 related mammalian cytokine polypeptides (IL-17E) |
| US20020177188A1 (en) | 1998-05-15 | 2002-11-28 | Genentech, Inc. | IL-17 homologous polypeptides and therapeutic uses thereof |
| US6569645B2 (en) | 1999-05-14 | 2003-05-27 | Genentech, Inc. | IL-17 homologous polypeptides and therapeutic uses thereof |
| WO1998049307A1 (en) | 1997-05-01 | 1998-11-05 | Zymogenetics, Inc. | Mammalian cytokine-like receptor |
| US5965704A (en) | 1997-08-05 | 1999-10-12 | Zymogenetics, Inc. | Class two cytokine receptor-11 |
| ATE442385T1 (de) | 1997-09-17 | 2009-09-15 | Human Genome Sciences Inc | Interleukin-17 rezeptor-ähnliches protein |
| JP2002533058A (ja) | 1998-05-12 | 2002-10-08 | ヒューマン ジノーム サイエンシーズ， インコーポレイテッド | ９７個のヒト分泌タンパク質 |
| US20030199041A1 (en) | 1999-07-07 | 2003-10-23 | Presnell Scott R. | Interleukin-17 receptor homologue |
| DE60045931D1 (de) | 1999-07-07 | 2011-06-16 | Zymogenetics Inc | Menschliches Rezeptor für Zytokine |
| CA2391374A1 (en) | 1999-12-23 | 2001-06-28 | Genentech, Inc. | Il-17 homologous polypeptides and therapeutic uses thereof |
| AU2001260847A1 (en) | 2000-05-24 | 2001-12-03 | Genesis Research And Development Corporation Limited | Compositions isolated from skin cells and methods for their use |
| CN1444652A (zh) | 2000-05-24 | 2003-09-24 | 先灵公司 | 哺乳动物受体蛋白;相关试剂和方法 |
| MXPA03003407A (es) * | 2000-10-18 | 2004-05-04 | Immunex Corp | Metodos para el tratamiento de artritis reumatoide usando antagonistas il-17. |
| WO2002038764A2 (en) * | 2000-11-10 | 2002-05-16 | The Regents Of The University Of California | Il-17 receptor-like protein, uses thereof, and modulation of catabolic activity of il-17 cytokines on bone and cartilage |
| US20040097447A1 (en) | 2002-11-16 | 2004-05-20 | Isis Pharmaceuticals Inc. | Modulation of interleukin 22 receptor expression |
| BRPI0511952A (pt) | 2004-06-10 | 2008-01-29 | Zymogenetics Inc | receptor solúvel isolado, anticorpo ou fragmento de anticorpo, e, métodos de reduzir inflamação induzida por il-17a ou induzida por il-17f, de tratar um mamìfero afetado com uma doença inflamatória, e uma condição patológica em um indivìduo associada com atividade de zcytor14 |
| EP2322553A3 (en) * | 2005-02-14 | 2011-11-16 | Wyeth LLC | Interleukin-17F antibodies and other IL-17F signaling antagonists and uses therefor |
| US20070249533A1 (en) * | 2005-09-28 | 2007-10-25 | Levin Steven D | Il-17a and il-17f antagonists and methods of using the same |
| EP1931697B1 (en) * | 2005-09-28 | 2010-09-15 | ZymoGenetics, Inc. | Il-17a and il-17f antagonists and methods of using the same |
-
2007
- 2007-02-09 CA CA002638819A patent/CA2638819A1/en not_active Abandoned
- 2007-02-09 US US11/673,094 patent/US7622116B2/en active Active
- 2007-02-09 ES ES07863316T patent/ES2347840T3/es active Active
- 2007-02-09 DE DE602007006429T patent/DE602007006429D1/de active Active
- 2007-02-09 JP JP2008554516A patent/JP2009526084A/ja active Pending
- 2007-02-09 EP EP07863316A patent/EP1987058B1/en not_active Not-in-force
- 2007-02-09 WO PCT/US2007/061909 patent/WO2008039553A1/en not_active Ceased
- 2007-02-09 AT AT07863316T patent/ATE467640T1/de active
- 2007-02-09 AU AU2007300393A patent/AU2007300393B2/en not_active Expired - Fee Related
-
2008
- 2008-07-22 IL IL192950A patent/IL192950A0/en unknown
-
2009
- 2009-10-15 US US12/580,112 patent/US8093355B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008509227A5 (enExample) | ||
| JP2009534297A5 (enExample) | ||
| JP2009510093A5 (enExample) | ||
| JP2020193195A5 (enExample) | ||
| EA035973B9 (en) | Amino acid sequences directed against il-17a, il-17f and/or il-17a/f and polypeptides comprising the same | |
| JP6181145B2 (ja) | 改善された特異性を有する新規免疫グロブリン結合タンパク質 | |
| US9920098B2 (en) | Protein ligand for affinity isolation matrix | |
| CN114957472B (zh) | 抗IL-4Rα的单域抗体以及应用和药物 | |
| RU2014102583A (ru) | Слитые серпиновые полипептиды и способы их применения | |
| FI3592384T3 (fi) | Vasta-aineita, jotka spesifisesti sitoutuvat ihmisen IL-1R7:ään | |
| RU2009124453A (ru) | Гетеродимерные полипептиды il-17 a/f и возможности их лечебного применения | |
| JP2017510575A5 (enExample) | ||
| CN104098694B (zh) | 抗人β2微球蛋白的单域抗体及其制备方法和用途 | |
| HRP20140150T1 (hr) | Antitijela koja vežu il-4 i/ili il-13 i njihova uporaba | |
| JP2008508885A5 (enExample) | ||
| RU2017118325A (ru) | Слитые серпиновые полипептиды и способы их применения | |
| JP2010220614A5 (enExample) | ||
| RU2016140572A (ru) | Конъюгаты антитело-финомер | |
| WO2007111714A3 (en) | Il-21 antagonists | |
| CN114478758B (zh) | 靶向SARS-CoV-2的纳米抗体及制备方法和应用 | |
| JP2016510736A5 (enExample) | ||
| JP2011520959A5 (enExample) | ||
| JPWO2017014261A1 (ja) | 抗体様タンパク質の精製方法 | |
| EP2322553A3 (en) | Interleukin-17F antibodies and other IL-17F signaling antagonists and uses therefor | |
| CN102942624A (zh) | 一种半乳糖凝集素-3结合蛋白及其制备和应用 |